Christine Bec - Sensorion Head Therapy

All Insiders . France . 
Stock . Sensorion SA . Stakeholders . Insider . Christine Bec
ALSEN Stock  EUR 0.62  0.02  3.13%   

Insider

Christine Bec is Head Therapy of Sensorion SA
Phone33 4 67 20 77 30
Webhttps://www.sensorion.com

Sensorion Management Efficiency

The company has return on total asset (ROA) of (0.238) % which means that it has lost $0.238 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.4994) %, meaning that it generated substantial loss on money invested by shareholders. Sensorion's management efficiency ratios could be used to measure how well Sensorion manages its routine affairs as well as how well it operates its assets and liabilities.
Sensorion SA has accumulated 3.36 M in total debt with debt to equity ratio (D/E) of 0.09, which may suggest the company is not taking enough advantage from borrowing. Sensorion SA has a current ratio of 13.2, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Sensorion until it has trouble settling it off, either with new capital or with free cash flow. So, Sensorion's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Sensorion SA sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Sensorion to invest in growth at high rates of return. When we think about Sensorion's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Pr StaelsGenfit
60
Laurent LannooGenfit
53
Stefanie MagnerGenfit
42
Sarah GaubertNanobiotix SA
N/A
Marc BonnevilleInnate Pharma
63
Pascal CaiseyGenfit
55
Jean FourniInnate Pharma
N/A
Laurent LevyNanobiotix SA
50
Elsa BorghiNanobiotix SA
N/A
Kathryn McNeilNanobiotix SA
48
Odile BelzunceInnate Pharma
43
Alain DostieNanobiotix SA
N/A
Thomas BaetzGenfit
49
Alessandro MDInnate Pharma
N/A
Brandon OwensNanobiotix SA
N/A
Mondher MDInnate Pharma
65
Pr PrasadNanobiotix SA
78
Emilie DesodtGenfit
40
Pascal PrigentGenfit
55
Bart RhijnNanobiotix SA
N/A
Earl BergeyNanobiotix SA
68
Sensorion SA, a clinical-stage biopharmaceutical company, develops therapies for the treatment of inner ear disorders in France. The company was founded in 2009 and is headquartered in Montpellier, France. SENSORION operates under Biotechnology classification in France and is traded on Paris Stock Exchange. It employs 33 people. Sensorion SA (ALSEN) is traded on Euronext Paris in France and employs 38 people.

Management Performance

Return On Equity-0.5
Return On Asset-0.24

Sensorion SA Leadership Team

Elected by the shareholders, the Sensorion's board of directors comprises two types of representatives: Sensorion inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sensorion. The board's role is to monitor Sensorion's management team and ensure that shareholders' interests are well served. Sensorion's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sensorion's outside directors are responsible for providing unbiased perspectives on the board's policies.
Nawal Ouzren, CEO Director
Geraldine MD, Chief Officer
Christine Bec, Head Therapy
Stephanie Filipe, Head Office
Catherine Leveau, Head Communication

Sensorion Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Sensorion a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity-0.5
Return On Asset-0.24
Operating Margin(4.64) %
Current Valuation(3.6 M)
Shares Outstanding79.94 M
Shares Owned By Insiders49.32 %
Shares Owned By Institutions27.00 %
Price To Earning(4.37) X
Price To Book0.97 X
Price To Sales6.58 X

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
ESRTEmpire State Realty
CCitigroup
CCitigroup

Additional Tools for Sensorion Stock Analysis

When running Sensorion's price analysis, check to measure Sensorion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sensorion is operating at the current time. Most of Sensorion's value examination focuses on studying past and present price action to predict the probability of Sensorion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sensorion's price. Additionally, you may evaluate how the addition of Sensorion to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY